Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Developing a new medication can cost over $1 billion, depending on the drug’s complexity and expenses accrued via unsuccessful studies. Considering these costs, an optimized regulatory process is ...

Celcuity, the Plymouth-based clinical-stage biotechnology company, has been the best-performing Minnesota stock of the summer ...